Почетна › Рак јајника › Florida › Orlando
Kliničke studije za Рак јајника u gradu Orlando, FL
24 studija za Рак јајника traži učesnike na lokacijama u gradu Orlando i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
Тражи се учесникФаза 1/2
- Florida Cancer Specialists Lake Nona, Orlando
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Тражи се учесникФаза 3
- Advent Health, Orlando
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
Тражи се учесникФаза 3
- Orlando Health Cancer Institute ( Site 0018), Orlando
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Тражи се учесникФаза 3
- Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085), Orlando
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Тражи се учесникФаза 3
- Orlando Health Cancer Institute, Orlando
- Orlando Health Cancer Institute - Doctor Phillips, Orlando
- Health Central, Ocoee · 10 ми удаљено
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Тражи се учесникФаза 3
- Site 0116, Orlando
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Тражи се учесникФаза 2
- Advent Health Cancer Institute, Orlando
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- AdventHealth Cancer Institute, Orlando
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Тражи се учесникОпсервациона студија
- Orlando Health, Orlando
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Тражи се учесникФаза 3
- AdventHealth Orlando, Orlando
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Тражи се учесникФаза 2
- Site 0308 - Advent Health, Orlando
- Site 0241 - Florida Cancer Specialist - North, Altamonte Springs · 9 ми удаљено
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Тражи се учесникФаза 1/2
- Florida Cancer Specialists - Lake Nona, Orlando
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Тражи се учесникФаза 3
- AdventHealth Cancer Institute, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 ми удаљено
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Тражи се учесникФаза 1/2
- Florida Cancer Specialists, Orlando
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Тражи се учесникФаза 2
- Orlando Health Cancer Institute Gynecologic Cancer Center - Orlando /ID# 278623, Orlando
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Advent Health, Orlando
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Тражи се учесникФаза 1
- Sara Cannon Research Institute Lake Nona, Orlando
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Тражи се учесникФаза 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Тражи се учесникФаза 3
- AdventHealth Cancer Institute, Orlando
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Тражи се учесникФаза 1
- Florida Cancer Specialists, Orlando
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Тражи се учесникФаза 1/2
- Florida Cancer Specialists, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Тражи се учесникФаза 1
- Dren Investigational Site, Orlando
Studije za Рак јајника u drugim gradovima
- Houston, TX90 студија
- New York City, NY75 студија
- Boston, MA62 студија
- Los Angeles, CA53 студија
- Nashville, TN50 студија
- Arlington, VA47 студија
- Philadelphia, PA47 студија
- Columbus, OH39 студија
- St. Louis, MO37 студија
- Chicago, IL36 студија
- San Antonio, TX33 студија
- Pittsburgh, PA32 студија
Ostale studije u gradu Orlando
- Немалоклетни карцином плућа47 студија
- Гојазност33 студија
- Алцхајмерова болест29 студија
- Метастатски карцином28 студија
- Гојазност27 студија
- Dijabetes tipa 225 студија
- Рак (све врсте)24 студија
- Рак дојке23 студија
- Рак плућа23 студија
- Ulcerativni kolitis21 студија
- Колоректални карцином21 студија
- Плоскоклеточни карцином главе и врата21 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.